COMMUNIQUÉS West-GlobeNewswire

SoldierStrong to Donate State-of-the-Art Exoskeleton to the South Texas Veterans Health Care System

10/01/2018 - 14:30

STAMFORD, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, today announced that it will be donating an EksoGT™ [...]

Marrone Bio Innovations Announces Availability of Next Generation Grandevo® WDG Bioinsecticide in California

10/01/2018 - 14:30

DAVIS, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy

10/01/2018 - 14:27

NEW HAVEN, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), today announced preliminary data from an ongoing study on the impact of academic pathology expertise on [...]

China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

10/01/2018 - 14:19

IRVINE, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) announced the China Food and Drug Administration (CFDA) approval of the EZ Detect™ colorectal screening test designed to help identify [...]

Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting

10/01/2018 - 14:00

DALLAS and FORT WORTH, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR [...]

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

10/01/2018 - 14:00

NORTHVALE, N.J., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) today reported positive topline results from pivotal bioequivalence studies for an undisclosed [...]

PositiveID Announces 2017 Highlights and Projects Continued 30% Growth

10/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 10, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today 2017 highlights for its [...]

Delcath Announces Special Protocol Agreement Modification With FDA

10/01/2018 - 14:00

NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has concluded a [...]

Vericel to Present at the 20th Annual Needham Growth Conference

10/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]

Atara Biotherapeutics Announces FDA Clearance to Proceed with Enrollment at U.S. Sites for Ongoing Global Phase 1 Clinical Study to Evaluate ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis

10/01/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4

10/01/2018 - 13:57

TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its latest assay for the [...]

Georgia Health Information Network (GaHIN) Awards $500,000 in Grants

10/01/2018 - 13:33

ATLANTA, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Georgia Health Information Network (GaHIN), the statewide health information exchange (HIE) for Georgia, awarded a total of $500,000 to its members in 2017 to accelerate [...]

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 for the Treatment of Narcolepsy

10/01/2018 - 13:30

DUBLIN, Ireland, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), “Avadel” or “the Company,” today announced that FT 218 has been granted Orphan Drug Designation from the U.S. Food and Drug [...]

FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity

10/01/2018 - 13:01

SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of a new [...]

Evogene Announces Positive 2nd Year Field Trial Results in Corn Bio-Stimulant Ag-Biologicals Program

10/01/2018 - 13:00

REHOVOT, Israel, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a proprietary [...]

Amedisys Honors 18 with Annual Spirit of Excellence Awards

10/01/2018 - 13:00

BATON ROUGE, La., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc., one of the nation’s leading home health, hospice and personal care companies in the nation, recognized 18 employees with the prestigious Spirit of [...]

Announcement no. 01/2018 - Coloplast completes acquisition of SAS Lilial

10/01/2018 - 11:22

Announcement No. 01/2018 10 January 2018 Coloplast completes acquisition of SAS Lilial Coloplast has now completed the acquisition of Lilial. All terms remain as stated in Coloplast’s stock exchange announcement no. 13/ [...]

RadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumors

10/01/2018 - 11:00

Houston, TX (USA) and Courbevoie (France), Jan. 10, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. and AREVA Med today announced the initiation in the United States of Phase 1 trial for AlphaMedix TM in patients with [...]

Medibio Announces ISO 13485 Certification

10/01/2018 - 11:00

SYDNEY, Australia and MINNEAPOLIS, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the Company’s Quality [...]